Hope for mitochondrial disease: new drug targets debilitating fatigue
Symptom relief
Recruiting now
This study tests whether the drug sonlicromanol can reduce fatigue and improve physical abilities like balance and leg strength in adults with a specific genetic form of mitochondrial disease. About 220 participants will take either the drug or a placebo twice daily for 52 weeks.…
Phase: PHASE3 • Sponsor: Khondrion BV • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC